# Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B

> **NCT00828100** · PHASE3 · SUSPENDED · sponsor: **Nanogen, Inc.** · enrollment: 650 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DEVICE:** fluID Rapid Influenza Test
- **DEVICE:** BinaxNOW® Influenza A & B

## Key facts

- **NCT ID:** NCT00828100
- **Lead sponsor:** Nanogen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2009-02
- **Primary completion:** 2009-05
- **Final completion:** —
- **Target enrollment:** 650 (ESTIMATED)
- **Why stopped:** Study currently suspended due to a lack of available funding.
- **Last updated:** 2009-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828100, "Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00828100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*